Krystal Biotech (KRYS) EBT Margin (2017 - 2026)
Krystal Biotech's EBT Margin came in at 62.94% for Q3 2026, up 13.89 percentage points from 49.05% a year earlier and up 7.51 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) EBT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Krystal Biotech reported EBT Margin of 55.06%, up 4.96 percentage points year-over-year; for FY2025, it was 48.69%, up 15.87 percentage points from FY2024.
- Going back by year, EBT Margin was 32.82% in FY2024 (+7.39 pp) and 25.44% in FY2023.
- The Q3 2026 figure represents the highest quarterly EBT Margin since Q3 2023.
- Year-over-year, EBT Margin has increased for three consecutive quarters, with an average year-over-year change of +16.65 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q1 2025 (a gain of 47.37 percentage points), and the weakest in Q3 2024 (a drop of 908.24 percentage points).
- Business Quant data shows KRYS's EBT Margin at 55.43% (Q2 2026), 52.79% (Q1 2026) and 47.74% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 62.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 62.94% |
| Jun 30, 2026 | 55.43% |
| Mar 31, 2026 | 52.79% |
| Dec 31, 2025 | 47.74% |
| Sep 30, 2025 | 49.05% |
| Jun 30, 2025 | 48.70% |
| Mar 31, 2025 | 49.43% |
| Dec 31, 2024 | 53.35% |
| Sep 30, 2024 | 35.51% |
| Jun 30, 2024 | 22.82% |
| Mar 31, 2024 | 2.06% |
| Dec 31, 2023 | 25.29% |
| Sep 30, 2023 | 943.75% |
| Jun 30, 2022 | -4,457.83% |
| Mar 31, 2022 | -19,541.63% |
| Dec 31, 2021 | -31,251.43% |
| Sep 30, 2021 | -24,844.44% |
| Jun 30, 2021 | -54,643.33% |
| Mar 31, 2021 | -48,015.15% |
| Dec 31, 2020 | -28,162.16% |
API Access
Krystal Biotech EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();